132 related articles for article (PubMed ID: 35656997)
1. Population Pharmacokinetics of Hydroxychloroquine Sulfate in Healthcare Workers, Given for Prophylaxis Against Coronavirus Disease 2019 (COVID-19) in India.
Raj JP; Gogtay NJ; Pandey A; Kakkar AK; Shafiq N; Mekala P; Pingali U; Raju AP; Mallayasamy S; Kshirsagar NA
J Clin Pharmacol; 2022 Nov; 62(11):1403-1411. PubMed ID: 35656997
[TBL] [Abstract][Full Text] [Related]
2. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
[TBL] [Abstract][Full Text] [Related]
3. Serosurvey for Health-Care Workers Provides Supportive Evidence for the Effectiveness of Hydroxychloroquine Prophylaxis against SARS-CoV-2 Infection.
Yadav RM; Pate A; Shankarkumar A; Athalye S; Shinde S; Bargir UA; Pate M; Ganpule M; Pruthi M; Patil H; Madkaikar MR
J Epidemiol Glob Health; 2021 Sep; 11(3):283-288. PubMed ID: 34514761
[TBL] [Abstract][Full Text] [Related]
4. Population Pharmacokinetics of Hydroxychloroquine in Japanese Patients With Cutaneous or Systemic Lupus Erythematosus.
Morita S; Takahashi T; Yoshida Y; Yokota N
Ther Drug Monit; 2016 Apr; 38(2):259-67. PubMed ID: 26587870
[TBL] [Abstract][Full Text] [Related]
5. Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial.
Rajasingham R; Bangdiwala AS; Nicol MR; Skipper CP; Pastick KA; Axelrod ML; Pullen MF; Nascene AA; Williams DA; Engen NW; Okafor EC; Rini BI; Mayer IA; McDonald EG; Lee TC; Li P; MacKenzie LJ; Balko JM; Dunlop SJ; Hullsiek KH; Boulware DR; Lofgren SM;
Clin Infect Dis; 2021 Jun; 72(11):e835-e843. PubMed ID: 33068425
[TBL] [Abstract][Full Text] [Related]
6. HCQ prophylaxis in COVID-19 did not show any QTc prolongation in Healthcare workers.
Jha S; Batra N; Siddiqui S; Yadav A; Misra A; Loomba M; Sethi S; Waghdhare S
Indian Heart J; 2021; 73(1):74-76. PubMed ID: 33714413
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine pre-exposure prophylaxis provides no protection against COVID-19 among health care workers: a cross-sectional study in a tertiary care hospital in North India.
Juneja S; Rana P; Chawla P; Katoch R; Singh K; Rana S; Mittal T; Kaur B; Kaur S
J Basic Clin Physiol Pharmacol; 2022 Jan; 33(1):103-107. PubMed ID: 34995022
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine for SARS CoV2 Prophylaxis in Healthcare Workers - A Multicentric Cohort Study Assessing Effectiveness and Safety.
Dinesh B; J CS; Kaur CP; Atiya F; Yk G; Avijit H; Sandhya K; Vp K; Rajani K; Nilima K; Subir M; Bikash M; Geetha M; Jaya R; Vishnu R; Yashashri S; Raakhi T; Denis X
J Assoc Physicians India; 2021 Jun; 69(6):11-12. PubMed ID: 34472778
[TBL] [Abstract][Full Text] [Related]
9. Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis.
Faruqui AR; Xavier D; Kamat SK; Chandy SJ; Medhi B; Tripathi RK; Shetty YC; Raj JM; Kaushal S; Balakrishnan S; Atal S; Tripathi SK; Badyal DK; Dikshit H; Roy SS; Trivedi N; Chatterjee S; Desai C; Tripathi CD; Rege NN; Gupta P; Raveendran R; Kaul R; Kshirsagar NA
Indian J Med Res; 2021 Jan & Feb; 153(1 & 2):219-226. PubMed ID: 33818480
[TBL] [Abstract][Full Text] [Related]
10. Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection?
Mehta S; Bhandari S; Mehta S
J Glob Antimicrob Resist; 2020 Sep; 22():864-865. PubMed ID: 32777441
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ).
Naggie S; Milstone A; Castro M; Collins SP; Lakshmi S; Anderson DJ; Cahuayme-Zuniga L; Turner KB; Cohen LW; Currier J; Fraulo E; Friedland A; Garg J; George A; Mulder H; Olson RE; O'Brien EC; Rothman RL; Shenkman E; Shostak J; Woods CW; Anstrom KJ; Hernandez AF;
Int J Infect Dis; 2023 Apr; 129():40-48. PubMed ID: 36682681
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19.
Zahr N; Urien S; Llopis B; Pourcher V; Paccoud O; Bleibtreu A; Mayaux J; Gandjbakhch E; Hekimian G; Combes A; Benveniste O; Saadoun D; Allenbach Y; Pinna B; Cacoub P; Funck-Brentano C; Salem JE
Therapie; 2021; 76(4):285-295. PubMed ID: 33558079
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
[TBL] [Abstract][Full Text] [Related]
15. System for administering and monitoring hydroxychloroquine prophylaxis for COVID-19 in accordance with a national advisory: preliminary experience of a tertiary care institute in India.
Kumar-M P; Mohindra R; Bhalla A; Shafiq N; Suri V; Kumari D; Pandey AK; Gupta A; Gupta PC; Patil A; Kakkar AK; Malhotra S
Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1331-1339. PubMed ID: 33781166
[TBL] [Abstract][Full Text] [Related]
16. Hydroxychloroquine Pre-Exposure Prophylaxis for COVID-19 in Healthcare Workers from India: A Meta-Analysis.
Stricker RB; Fesler MC
J Infect Public Health; 2021 Sep; 14(9):1161-1163. PubMed ID: 34391171
[TBL] [Abstract][Full Text] [Related]
17. Post-exposure prophylaxis with hydroxychloroquine for the prevention of COVID-19, a myth or a reality? The PEP-CQ Study.
Dhibar DP; Arora N; Kakkar A; Singla N; Mohindra R; Suri V; Bhalla A; Sharma N; Singh MP; Prakash A; Pvm L; Medhi B
Int J Antimicrob Agents; 2020 Dec; 56(6):106224. PubMed ID: 33166694
[TBL] [Abstract][Full Text] [Related]
18. Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection.
Infante M; Ricordi C; Alejandro R; Caprio M; Fabbri A
Expert Rev Anti Infect Ther; 2021 Jan; 19(1):5-16. PubMed ID: 32693652
[TBL] [Abstract][Full Text] [Related]
19. QTc Interval of Healthcare Workers from India: Baseline and Effect of Hydroxychloroquine Prophylaxis during the COVID-19 Pandemic.
Gutte S; Gurjar M; Sanjeev OP; Bhadauria D; Kapoor A; Mishra P; Azim A; Poddar B
Indian J Community Med; 2023; 48(3):497-500. PubMed ID: 37469913
[TBL] [Abstract][Full Text] [Related]
20. Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
Nina PB; Dash AP
Indian J Public Health; 2020 Jun; 64(Supplement):S125-S127. PubMed ID: 32496241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
